Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (581-590 of 799) with videos related to

Pageof 80
Sort By:
Neuro-Oncology Advances|November 18, 2020
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomasMatthew K Ball, Thomas M Kollmeyer, Corinne E Praska, et al.
Medical Epigenetics|August 4, 2015
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisAbdirashid Shire, Gwen Lomberk, Jin-Ping Lai, et al.
American Journal of Clinical Pathology|July 28, 2010
Comparison of central HER2 testing with quantitative total HER2 expression and HER2 homodimer measurements using a novel proximity-based assayWeidong Huang, Monica Reinholz, Jodi Weidler, et al.
Cancer Research|April 15, 2010
Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomasAaron M Bender, Lara S Collier, Fausto J Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivorsEric C Burton, Kathleen R Lamborn, Peter Forsyth, et al.
American Journal of Clinical Pathology|May 4, 2021
Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization ResultsKatherine B Geiersbach, Daniel R Sill, Kristina M Del Rosario, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experienceJames L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Cancer Research|September 24, 2009
Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromesDavid P Steensma, Jessemy D Neiger, Julie C Porcher, et al.
Journal of Neuro-Oncology|June 20, 2015
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131Michael A Vogelbaum, Chen Hu, David M Peereboom, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Pageof 80

Showing results (581-590 of 799) with videos related to

Sort By:
Pageof 80
Neuro-Oncology Advances|November 18, 2020
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomasMatthew K Ball, Thomas M Kollmeyer, Corinne E Praska, et al.
Medical Epigenetics|August 4, 2015
Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisAbdirashid Shire, Gwen Lomberk, Jin-Ping Lai, et al.
American Journal of Clinical Pathology|July 28, 2010
Comparison of central HER2 testing with quantitative total HER2 expression and HER2 homodimer measurements using a novel proximity-based assayWeidong Huang, Monica Reinholz, Jodi Weidler, et al.
Cancer Research|April 15, 2010
Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomasAaron M Bender, Lara S Collier, Fausto J Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivorsEric C Burton, Kathleen R Lamborn, Peter Forsyth, et al.
American Journal of Clinical Pathology|May 4, 2021
Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization ResultsKatherine B Geiersbach, Daniel R Sill, Kristina M Del Rosario, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2006
Central neurocytoma: management recommendations based on a 35-year experienceJames L Leenstra, Fausto J Rodriguez, Christina M Frechette, et al.
Cancer Research|September 24, 2009
Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromesDavid P Steensma, Jessemy D Neiger, Julie C Porcher, et al.
Journal of Neuro-Oncology|June 20, 2015
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131Michael A Vogelbaum, Chen Hu, David M Peereboom, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Pageof 80